Used in pharmaceutical research as a chiral intermediate for synthesizing bioactive molecules, particularly in the development of fluorinated compounds with potential neurological activity. Its structure supports high selectivity in receptor binding, making it valuable in creating targeted therapies for central nervous system disorders. Also employed in studies exploring the metabolic stability of trifluoroethyl-containing drugs due to enhanced lipophilicity and resistance to oxidative degradation.